KENDALL NOBLES: Open Payments
NPI 1912441726 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 60 payments from 16 companies in 2025. Trend: 2023 $1,328 · 2024 $981 · 2025 $971
Food & beverage: $971
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 23 | $242 |
| Novo Nordisk Inc | 8 | $152 |
| Lilly USA, LLC | 5 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $81 |
| Sumitomo Pharma America, Inc. | 1 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| Exact Sciences Corporation | 3 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Astellas Pharma US Inc | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $38 |
Products named: ZORYVE, JARDIANCE, GEMTESA, Ozempic, Kerendia, CAPLYTA, Rybelsus, Wegovy.
Industry payments across TX — which companies pay providers there.
